Cargando…
Clinical Utility and Validation of the Krakow DCM Risk Score—A Prognostic Model Dedicated to Dilated Cardiomyopathy
Background: One of the most common causes of heart failure is dilated cardiomyopathy (DCM). In DCM, the mortality risk is high and reaches approximately 20% in 5 years. A patient’s prognosis should be established for appropriate HF management. However, so far, no validated tools have been available...
Autores principales: | Dziewięcka, Ewa, Winiarczyk, Mateusz, Wiśniowska-Śmiałek, Sylwia, Karabinowska-Małocha, Aleksandra, Gliniak, Matylda, Robak, Jan, Kaciczak, Monika, Leszek, Przemysław, Celińska-Spodar, Małgorzata, Dziewięcki, Marcin, Rubiś, Paweł |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879244/ https://www.ncbi.nlm.nih.gov/pubmed/35207723 http://dx.doi.org/10.3390/jpm12020236 |
Ejemplares similares
-
Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model
por: Dziewięcka, Ewa, et al.
Publicado: (2020) -
Relationships between Pulmonary Hypertension Risk, Clinical Profiles, and Outcomes in Dilated Cardiomyopathy
por: Dziewięcka, Ewa, et al.
Publicado: (2020) -
Lack of Relationship between Fibrosis-Related Biomarkers and Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis in Dilated Cardiomyopathy
por: Rubiś, Paweł, et al.
Publicado: (2021) -
Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy
por: Rubiś, Paweł, et al.
Publicado: (2016) -
The Relationship between Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy
por: Karabinowska-Małocha, Aleksandra, et al.
Publicado: (2022)